BBNR Personal Injury Attorneys Remind New York Drivers that Consuming Alcohol or Drugs Can Lead to Fatal Motor Vehicle Accidents
A recent study implicates drugs and alcohol as a significant factor in fatal car crashes.
New York, NY (PRWEB) September 12, 2012
Using data from the Fatality Analysis Reporting System for 2005–09, the authors of a recent study examined the prevalence of alcohol or drugs (AOD) detected in fatally injured drivers in the United States. The study concluded that more than half of fatally injured drivers in the United States had been using AOD and approximately 20% had been using polydrugs.
Defensive driving is a critical skill in avoiding a motor vehicle accident. Any substance that alters a person’s reaction time such as marijuana, alcohol, or certain prescription medications will increase the chances of being seriously injured or killed in a car accident.
The attorneys at Brand Brand Nomberg & Rosenbaum, LLP aggressively litigate personal injury cases against drivers who cause accidents through negligence, which includes consuming substances that alter a driver’s perception and reaction time.
In New York State, the time to commence a negligence suit involving a car accident is generally three years from the date of accident. However, there are many exceptions depending upon who is injured and who the potential defendant is for the lawsuit. Computing the statutory time limitation is not always a simple matter and a person should promptly consult an experienced new york motor vehicle accident attorney to get the right legal advice.
The attorneys at BBNR will immediately answer all your questions about your potential personal injury case and make sure all the necessary paperwork is filed to protect your interests. Whether you are involved in a truck, car, bus, SUV or motorcycle accident, the attorneys at BBNR are experienced to give each client the representation they need. All consultations are free and BBNR has paralegals who speak Spanish, Polish, and Russian.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/9/prweb9876912.htm